Ohsu Knight Cancer Institute
Clinical trials sponsored by Ohsu Knight Cancer Institute, explained in plain language.
-
Can smartphone cameras spot skin cancer? new study investigates
Diagnosis TerminatedThis study tested three portable imaging systems (MoleMapper, Visiomed, and confocal microscopy) to see how well they could screen for melanoma. Researchers compared the images to a dermatologist's exam. The goal was to find out if these devices could help detect skin cancer earl…
Phase: NA • Sponsor: OHSU Knight Cancer Institute • Aim: Diagnosis
Last updated May 26, 2026 05:09 UTC
-
New MRI technique could spot fake tumor growth in brain cancer patients
Diagnosis TerminatedThis study looked at whether a special MRI using ferumoxytol (an iron-based contrast agent) can tell the difference between true tumor growth and treatment-related inflammation (pseudoprogression) in people with glioblastoma receiving immunotherapy. About 52 adults with newly dia…
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Diagnosis
Last updated May 18, 2026 12:03 UTC
-
AI-Powered home skin check could revolutionize cancer detection
Diagnosis TerminatedThis study tested whether an at-home artificial intelligence system called Sklip can help people safely check their own moles and skin spots for signs of cancer. The goal was to see if the system could accurately identify which spots need a biopsy, potentially reducing unnecessar…
Phase: NA • Sponsor: OHSU Knight Cancer Institute • Aim: Diagnosis
Last updated May 11, 2026 20:39 UTC
-
Cancer trial uses DNA tests to pick drugs, but stops early
Knowledge-focused TerminatedThis study tested a precision medicine approach for people with advanced cancers like breast, prostate, or pancreatic cancer. Researchers used genetic and protein tests to track how each person's cancer changed over time, then a team of experts recommended personalized drugs. The…
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Knowledge-focused
Last updated May 26, 2026 05:15 UTC